A Phase 1 Study of Nilotinib Plus Radiation in High-Risk Chordoma.
Cote GM, Barysauskas CM, DeLaney TF, Schwab J, Raskin K, Lozano-Calderon S, Bernstein K, Mullen JT, Haynes AB, Hornicek F, Chen YE, Choy E.
Cote GM, et al. Among authors: chen ye.
Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1496-1504. doi: 10.1016/j.ijrobp.2018.07.2013. Epub 2018 Aug 3.
Int J Radiat Oncol Biol Phys. 2018.
PMID: 30077789
Clinical Trial.